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Abstract
Photodynamic Therapy (PDT) is a cancer treatment that used the interaction of 
a photosensitizing drug and a light source. PDT can lead to changes in the expression 
of various cellular elements, compromising cell adhesion, and cytoskeleton integrity 
in cells undergoing treatment. However, the pathways of cellular alterations caused 
by this treatment are little known. Alterations in expression in surface glycoproteins 
and glycolipids are significant features in malignant tumor transformation and are 
strongly associated with tumor cell adhesion, invasion, and metastasis. This study 
evaluated photodynamic therapy effects on indirect distribution surface glyco-
proteins in human laryngeal carcinoma HEp-2 cell line surface, using Click-iT™ 
Metabolic Glycoprotein Labeling Reagent. Aluminum Phthalocyanine Tetrasulfonate 
(AlPcS4) was administrated at 5 μM/mL, followed by one hour of the incubation 
period for its accumulation in the tumor cells. After this time, cultures were irradi-
ated with LED (light-emitting diode) dispositive (BioPdi/IRRAD-LED) λ = 660 nm. 
Evaluation of glycoproteins was performed by flow cytometry. Knowledge of 
the cellular alterations caused by the treatment will allow obtaining tools for the 
potentiation or optimization and personalization of the anticancer treatment. This 
therapy has a low cost and better efficacy, when applied early, about radiotherapy 
chemotherapy.
Keywords: glycosylation, flow cytometry, cell culture, aluminum phthalocyanine 
tetrasulfonate
1. Introduction
Photodynamic therapy (PDT) is an oncology treatment based on photochemi-
cal reactions involved photosensitizer (PS) and light irradiation of an appropriate 
wavelength. The interaction of PS and light, producing reactive oxygen species 
(ROS), can directly induce cellular damage to organelles and cell membranes. 
PDT’s action on cellular organelles, mainly in the endoplasmic reticulum (ER) and 
Golgi, interferes with several metabolic pathways [1]. The glycosylation process is 
a post-translational modification that occurs in the ER [2]. It results in the addi-
tion of carbohydrate motifs—glycans to proteins that are, in most cases, destined 
for the cell surface. The resultant glycoprotein structures at the cell surface form 
a carbohydrate-rich layer, which presents an essential role in the cell’s interaction 
with its surrounding environment. Glycosylation of a given protein is a process 
catalyzed by glycosyltransferases, localized in the Golgi, leading to the formation of 
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protein-bound glycans with specific and diverse biological functions [3]. These car-
bohydrate side chains can modulate the protein’s interaction with its environment, 
influencing key factors such as protein half-life, solubility, binding activity, and 
specificity. Two significant types of glycosylation occur on proteins. (1) O-linked 
glycosylation refers to the addition of N-acetyl-galactosamine to serine or threonine 
residues by the enzyme UDP-N-acetyl-D-galactosamine transferase, followed by the 
addition of other carbohydrates, such as galactose, N-acetyl-D-glucosamine, or sialic 
acid; (2) N-linked glycosylation occurs in the ER [4, 5]. It refers to the insertion of 
an oligosaccharide chain enzymatically attached to the amide group of asparagine 
in the consensus sequence Asn-X-Ser/Thr (where X represents any residue except 
proline). Alterations in glycosylation of malignant cells can take a variety of forms, 
including changes in the amount, linkage, and acetylation of sialic acids; changes 
in the branching of N-glycans mediated by glycosyltransferases; alterations in the 
expression of glycosaminoglycans such as heparan sulfate; and altered glycosylation 
of mucins, which are heavily glycosylated epithelial-derived proteins known to be 
implicated in certain cancers [5, 6].
Changes in glycoprotein glycans are significant in malignant tumor transforma-
tion and are closely associated with tumor cell adhesion, invasion, and metastasis 
[7]. Christiansen et al., 2014 [8] demonstrated changes in cell surface glycosylation in 
five different types of cancer: breast, colon, liver, skin (melanoma), and ovarian, and 
how these changes may be associated with carcinogenesis. Synthesis and expression 
of cell-surface carbohydrates is a highly regulated process that affects several cell-
cell interactions. The presence of specific oligosaccharides in highly malignant cells 
is essential for expressing the metastatic phenotype [9]. Elevation of glycoproteins 
above normal levels reflects local tissue destruction processes with the release of 
preformed tissue proteins or becomes a local synthesis and releases glycoproteins 
through tumor cells [10].
Waiting for glycans and glycoconjugates to play a relevant role in various tumor 
progression stages, biosynthetic cell machinery involved in glycan biosynthesis and 
modification is a promising target for cancer treatment. Treatments that act on such 
targets should be researched to act or stimulate specific glycosylation inhibitors 
that may target a pro-metastatic biological product or interfere with the immune 
response’s modulation.
2. Methods
2.1 Cell culture
The HEp-2 cell line (human laryngeal carcinoma) and MCF7 cell line (human 
mammary carcinoma) were obtained from the Bank of Cells of Rio de Janeiro 
(BCRJ). Cells were cultured in 25 cm2 culture flask (Greiner), routinely maintained 
in Dulbecco’s Modified Eagles Medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS), 1% antibiotic-antimycotic (Gibco-Life-Technology), at 37°C, 
an atmosphere containing 5% CO2 (Forma Scientific CO2, MODEL 3110).
2.2 Photosensitizer
Aluminum phthalocyanine tetrasulfonate (AlPcS4-Frontier Scientific) at a 
5 μM/mL concentration is diluted in phosphate-buffered saline (PBS).
Experimental groups HEp-2 cells were divided into four groups: control, a 
photosensitizer (cells incubated with AlPcS4), laser (irradiated cells only), and 
photodynamic therapy (PDT) (cells incubated with AlPcS4 and irradiated).
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2.3 Photodynamic therapy
Cells were cultivated in 6-well plates at a density of 1 × 106 cells/well, at 37°C in 
a 5% CO2 atmosphere, and incubated for 18 hours for cell adhesion. After plating, 
cells were incubated with AlPcS4 for 1 hour at 37°C in an atmosphere containing 5% 
CO2. Then, they were washed with PBS to remove the photosensitizer not absorbed 
by the cells. Irradiation was performed by using a LED dispositive (Biopdi/IRRAD-
LED) λ = 660 nm. Each well was exposed to 25 mW, an energy density of 5 J/cm2. 
Immediately after treatment, all groups were incubated with 25 μM Click-iT™ 
Metabolic Glycoprotein Labeling (according to the manufacturer’s instructions, 
Thermo Fisher Scientific™- Table 1) for 24 and 48 hours to evaluate the changes in 
the protein glycosylation process by the Golgi complex (Figure 1). At the end of the 
incubation periods, the cells were scraped, added into 5 ml tubes, and centrifuged at 
5259 g at 4°C for 5 minutes for cell sedimentation. After this, cells were resuspended 
and washed in PBS 2 times, fixed with 4% paraformaldehyde in PBS for 15 minutes, 
washed two more times with PBS, and permeabilized with 0.25% Triton x-100 in 
PBS for 15 minutes, washed with 3% BSA in PBS twice, and then incubated with an 
FTIC-conjugated antibody for one hour while diluted 1: 1000 in a Click-iT reaction 
buffer for one hour. At the end of the incubation period, it was washed with PBS, 
resuspended in the Click-iT reaction buffer, and read by BD AccuriC6 Plus flow 
cytometer. All experiments were performed in duplicate (n = 6).
Markers Target Incubation time
Click-iT®
GalNAz
O-linked glycans 24–72 hours
Click-iT®
ManNAz
Sialic acid-modified glycoproteins 24–72 hours
Click-iT®
GlcNAz
O-GLcNAz-modified glycoproteins 24–72 hours
Table 1. 
The markers used to evaluate glycoproteins.
Figure 1. 
Scheme of the experimental procedure. C – Control; PS – Photosensitizer; L – Led only; T – Treatment = PS + Led. 
Created with BioRender.com.
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2.4 Statistical analysis
The data presented are in the form of mean and standard deviation, compared by 
the two-way ANOVA test and confirmed by the Tukey test. Statistical significance 
was admitted with P < 0.05 with *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 
being considered significant. Experiments were performed in three independent 
replications with n = 8. GraphPad Prism 6® software was used to per-form statistical 
and graphical analyses.
3. Results
The evaluation of the glycoprotein synthesis by Flow Cytometry demonstrates 
that the modified sialic acid glycoproteins (Click-iT® ManNAz - Figure 2) in the 
treatment group present a higher fluorescence intensity in 24 hours, concerning 
the O-GLcNAz-modified glycoproteins and the O- glycans linked. The HEp-2 
strain presents the synthesis of sialic acid-modified glycoproteins and O-GlcNAz-
modified effectively in the first 24 hours; after 48 hours, a decrease in the synthesis 
of these glycoproteins is observed (Figures 3 and 4). They were probably modified 
due to the action of glycosidases and glycosyltransferases, changing their struc-
tures. O-linked glycans are less fluorescent in the first 24 hours; however, in the 
group treated within 48 hours, an increase in the synthesis of these glycoproteins is 
observed, which can be considered a possible target for photodynamic treatment.
4. Discussion
The use of the technique called metabolic oligosaccharide engineering (metabolic 
oligosaccharide engineering) allows for the labeling of glycans with probes for 
Figure 2. 
Analysis of cells treated with Click-iT®-ManNAz, the graph shows the fluorescence intensity of the cells of 
the control, LED, and treatment groups in the periods of 24 and 48 hours. The treatment group showed a high 
fluorescence intensity within 24 hours, with a severe fluorescence reduction occurring in all groups within 
48 hours.
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visualization in cells by enriching specific types of glycoconjugates for proteomic 
analysis. This methodology promotes the metabolic labeling of glycans with a 
specific reactive functional group, the azide. Azide-labeled carbohydrates are endo-
cytosed by cells and integrated with glycan biosynthesis in various glycoconjugates. 
The cells are incubated for periods of 24 to 72 hours to allow the synthesis of surface 
glycoproteins to be monitored [11, 12].
According to prior research [13, 14], glycosylation markers can assist in cancer 
detection and monitoring since the malignant transformation of cancer cells 
Figure 3. 
Analysis of cells treated with Click-iT®-GlcNAz, the graph shows the fluorescence intensity of the cells of the 
control, led, and treatment groups in the periods of 24 and 48 hours. The fluorescence intensity in all groups in 
the 24 hours is the same for all. Within 48 hours it is possible to observe an increase in fluorescence intensity in 
the treatment group compared the control and LED groups.
Figure 4. 
Analysis of cells treated with Click-iT®-GalNAz, the graph shows the fluorescence intensity of the cells of the 
control, LED, and treatment groups in the periods of 24 and 48 hours. The treatment group, compared to the 
other groups, has a high fluorescence intensity.
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associated with changes in cell glycosylation are associated with tumor progression 
and, finally, metastasis. The schemes shown above demonstrate the biosynthesis of 
glycoproteins in a normal cell (Figure 5). The results obtained demonstrate indi-
rectly that the photodynamic treatment altered the glycosylation of proteins in the 
lattice, consequently compromising the glycosylation in the Golgi and the insertion 
of glycoproteins in the plasma membrane (Figure 6). The statement concerning 
the reticule is based on previous data obtained by our group, which demonstrated 
changes in the reticular tubular network and the presence of surface glycoproteins 
N-acetyl glucosamine terminals [15, 16].
The glycoproteins, when sent via vesicle traffic to the Golgi complex, change 
with the removal of mannose residues, the addition of N-acetyl glucosamine, 
galactose, and sialic acid. The addition of carbohydrates is associated with the 
function that the glycoprotein will play on the cell surface.
The glycosylation markers can be used for cancer detection and monitoring, 
since changes in cell glycosylation are associated with the transformation of cancer 
cells into glycosylation, tumor progression, and, finally, metastasis [13, 14]. The 
schemes shown above demonstrate the biosynthesis of glycoproteins in a normal 
cell (Figures 7 and 8). The results obtained indirectly demonstrate that the photo-
dynamic treatment altered the glycosylation of proteins in the lattice, consequently 
compromising the glycosylation in the Golgi and the insertion of glycoproteins in 
the plasma membrane. The reticule statement is based on previous data obtained by 
our group [15], which demonstrated changes in the reticular tubular network.
The photodynamic treatment action on surface glycans has a significant impact 
on cell signaling and the regulation of cell-tumor cell adhesion and cell-matrix 
interaction, compromising the interaction between cancer cells and the tumor 
microenvironment.
An exciting result refers to the AlPcS4 group, with reduced glycosylation of 
proteins with mannose and galactose terminal monosaccharides, when compared 
Figure 5. 
Membrane glycoprotein biosynthesis scheme. The monosaccharide complexed with azide (Click-iT™ Metabolic 
Glycoprotein Labeling Reagent), crosses the plasma membrane, becoming available in the cytoplasm. Golgi, 
responsible for the glycosylation process, captures the monosaccharide, which will be used in the processing 
of membrane protein, coming from the rough endoplasmic reticulum. After the incorporation of the labeled 
monosaccharide into the protein, the vesicle is released and fused to the plasma membrane, exposing the 
glycoprotein, allowing its detection by microscopy or cytometry. Created with BioRender.com.
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to the control group. This data suggests that phthalocyanine endocytosed by the 
tumor cell requires more lysosomes to be degraded, a demand supplied by Golgi, 
which releases transport vesicles with acid hydrolases to the lysosomes via the 
mannose −6-phosphate receptor. For the substitution of mannose by galactose, 
mannosidase action must occur; however, as there is a need for more hydrolases and 
more transporters, the final carbohydrate does not change.
In the 48 hours, the AlPcS4 and LED groups show similar behavior to the control 
group, indicating that, after the period of interaction with the photosensitizer and 
the action of light, the cell restores its synthesis process. Reinforcing the informa-
tion that light and separate photosensitizers cannot cause damage to cells.
Figure 6. 
Membrane glycoprotein biosynthesis scheme after PDT. The monosaccharide complexed with azide (Click-iT™ 
metabolic glycoprotein labeling reagent), crosses the plasma membrane, becoming available in the cytoplasm. 
Golgi, responsible for the glycosylation process, captures the monosaccharide, which will be used in the processing 
of membrane protein, coming from the rough endoplasmic reticulum, but after PDT changes the sequence 
of monosaccharides, modifies the glycan modifying the glycoprotein. After the incorporation of the labeled 
monosaccharide into the protein, the vesicle is released and fused to the plasma membrane, exposing the 
glycoprotein, allowing its detection by microscopy or cytometry. Created with BioRender.com.
Figure 7. 
Glycosylation scheme in the rough endoplasmic reticulum. Created with BioRender.com.
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5. Conclusion
The action of photodynamic treatment on surface glycans has a significant 
impact on cell signaling and the regulation of cell-tumor, cell-adhesion, and 
cell-matrix interactions, compromising the interaction between cancer cells and 
the tumor microenvironment. The involvement of the glycosylation process in 
the Golgi apparatus prejudice the survival of tumor cells and can be exploited to 
develop strategies for immune system activation.
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